Filing Details
- Accession Number:
- 0001209191-16-132504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-13 13:25:22
- Reporting Period:
- 2016-07-11
- Filing Date:
- 2016-07-13
- Accepted Time:
- 2016-07-13 13:25:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594935 | Russell Lawrence Smith | 10390 Pacific Center Court San Diego CA 92121 | Vp, Vaccine Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2016-07-11 | 54 | $4.46 | 23,179 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of 54 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on June 6, 2016.
- Such number reflects the 1-for-10 reverse stock split of the issuer's common stock on May 26, 2016, resulting in the Reporting Person's ownership of 209,098 fewer shares of common stock. The balance includes 6,523 unvested shares subject to restricted stock units.
Billionaire Hedge Funds
